FINKELSTEIN J J

PrivateCIK: 1125610

FINKELSTEIN J J

Filed: 5/17/2019ACC: 0000914190-19-000164

InsiderFINKELSTEIN J JCIK 1125610

→

IssuerREGENERX BIOPHARMACEUTICALS INCCIK 707511

DirectorOfficer· President and CEO

Since Jul 2018

+650K

Net shares

Net buyer

$0.00

Total acquired

0

Open market trades

0B · 0S

1

Total transactions

650K acquired

Non-Derivative Transactions0

No non-derivative transactions reported

Derivative Transactions1

Stock Option (right to buy)

Direct

A · Award

Converts to

Common Stock

650K shares

Shares

+650K

Strike price

.21

Held after

650K

Exercisable

—

5/15/2019

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option (right to buy) Direct	Common Stock650K shares	5/15/2019	A · Award	+650K	.21	—	650K

Non-Derivative Holdings (Post-Transaction)1

Common Stock

Direct

Shares owned1.64M

Total

1.64M direct1.64M

Security Title	Shares Owned	Ownership Type
Common Stock	1.64M	Direct
Total	1.64M	1.64M direct

Derivative Holdings (Post-Transaction)9

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

.21

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

150K

Shares owned

150K

Exercise price

.28

Expiration

—

Exercise window

—

Common Stock Warrant (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

.18

Expiration

—

Exercise window

—

Convertible Promissory Note (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

.12

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

200K

Shares owned

200K

Exercise price

.64

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

250K

Shares owned

250K

Exercise price

.21

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

.36

Expiration

—

Exercise window

—

Convertible Promissory Note (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

.12

Expiration

—

Exercise window

—

Common Stock Warrant (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

.18

Expiration

—

Exercise window

—

Total

Underlying

1.96M

Owned

1.76M

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (right to buy) Direct	Common Stock	.21	—	—	500K	500K
Stock Option (right to buy) Direct	Common Stock	.28	—	—	150K	150K
Common Stock Warrant (right to buy) Direct	Common Stock	.18	—	—	78.13K	78.13K
Convertible Promissory Note (right to buy) Direct	Common Stock	.12	—	—	104.17K	N/A
Stock Option (right to buy) Direct	Common Stock	.64	—	—	200K	200K
Stock Option (right to buy) Direct	Common Stock	.21	—	—	250K	250K
Stock Option (right to buy) Direct	Common Stock	.36	—	—	500K	500K
Convertible Promissory Note (right to buy) Direct	Common Stock	.12	—	—	104.17K	N/A
Common Stock Warrant (right to buy) Direct	Common Stock	.18	—	—	78.13K	78.13K
Total					1.96M	1.76M

FINKELSTEIN J J — Insider Transaction (Form 4) Filed May 17, 2019 | Finecho